246 related articles for article (PubMed ID: 37463901)
1. Distinct shared and compartment-enriched oncogenic networks drive primary versus metastatic breast cancer.
Jiang Z; Ju Y; Ali A; Chung PED; Skowron P; Wang DY; Shrestha M; Li H; Liu JC; Vorobieva I; Ghanbari-Azarnier R; Mwewa E; Koritzinsky M; Ben-David Y; Woodgett JR; Perou CM; Dupuy A; Bader GD; Egan SE; Taylor MD; Zacksenhaus E
Nat Commun; 2023 Jul; 14(1):4313. PubMed ID: 37463901
[TBL] [Abstract][Full Text] [Related]
2. Ras Signaling Is a Key Determinant for Metastatic Dissemination and Poor Survival of Luminal Breast Cancer Patients.
Wright KL; Adams JR; Liu JC; Loch AJ; Wong RG; Jo CE; Beck LA; Santhanam DR; Weiss L; Mei X; Lane TF; Koralov SB; Done SJ; Woodgett JR; Zacksenhaus E; Hu P; Egan SE
Cancer Res; 2015 Nov; 75(22):4960-72. PubMed ID: 26400062
[TBL] [Abstract][Full Text] [Related]
3. Single allele loss-of-function mutations select and sculpt conditional cooperative networks in breast cancer.
Schachter NF; Adams JR; Skowron P; Kozma KJ; Lee CA; Raghuram N; Yang J; Loch AJ; Wang W; Kucharczuk A; Wright KL; Quintana RM; An Y; Dotzko D; Gorman JL; Wojtal D; Shah JS; Leon-Gomez P; Pellecchia G; Dupuy AJ; Perou CM; Ben-Porath I; Karni R; Zacksenhaus E; Woodgett JR; Done SJ; Garzia L; Sorana Morrissy A; Reimand J; Taylor MD; Egan SE
Nat Commun; 2021 Sep; 12(1):5238. PubMed ID: 34475389
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line.
Bjorge JD; Pang AS; Funnell M; Chen KY; Diaz R; Magliocco AM; Fujita DJ
PLoS One; 2011 Apr; 6(4):e19309. PubMed ID: 21541295
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing of primary breast cancers with paired metastatic lesions reveals metastasis-enriched mutations in the A-kinase anchoring protein family (AKAPs).
Kjällquist U; Erlandsson R; Tobin NP; Alkodsi A; Ullah I; Stålhammar G; Karlsson E; Hatschek T; Hartman J; Linnarsson S; Bergh J
BMC Cancer; 2018 Feb; 18(1):174. PubMed ID: 29433456
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone.
Liu S; Goldstein RH; Scepansky EM; Rosenblatt M
Cancer Res; 2009 Nov; 69(22):8742-51. PubMed ID: 19887617
[TBL] [Abstract][Full Text] [Related]
7. Two distinct mTORC2-dependent pathways converge on Rac1 to drive breast cancer metastasis.
Morrison Joly M; Williams MM; Hicks DJ; Jones B; Sanchez V; Young CD; Sarbassov DD; Muller WJ; Brantley-Sieders D; Cook RS
Breast Cancer Res; 2017 Jun; 19(1):74. PubMed ID: 28666462
[TBL] [Abstract][Full Text] [Related]
8. Targeting IL13Ralpha2 activates STAT6-TP63 pathway to suppress breast cancer lung metastasis.
Papageorgis P; Ozturk S; Lambert AW; Neophytou CM; Tzatsos A; Wong CK; Thiagalingam S; Constantinou AI
Breast Cancer Res; 2015 Jul; 17(1):98. PubMed ID: 26208975
[TBL] [Abstract][Full Text] [Related]
9. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer.
Guo BH; Feng Y; Zhang R; Xu LH; Li MZ; Kung HF; Song LB; Zeng MS
Mol Cancer; 2011 Jan; 10(1):10. PubMed ID: 21276221
[TBL] [Abstract][Full Text] [Related]
10. Cross-species DNA copy number analyses identifies multiple 1q21-q23 subtype-specific driver genes for breast cancer.
Silva GO; He X; Parker JS; Gatza ML; Carey LA; Hou JP; Moulder SL; Marcom PK; Ma J; Rosen JM; Perou CM
Breast Cancer Res Treat; 2015 Jul; 152(2):347-56. PubMed ID: 26109346
[TBL] [Abstract][Full Text] [Related]
11. Distinct phosphotyrosine-dependent functions of the ShcA adaptor protein are required for transforming growth factor β (TGFβ)-induced breast cancer cell migration, invasion, and metastasis.
Northey JJ; Dong Z; Ngan E; Kaplan A; Hardy WR; Pawson T; Siegel PM
J Biol Chem; 2013 Feb; 288(7):5210-22. PubMed ID: 23277357
[TBL] [Abstract][Full Text] [Related]
12. Integrated molecular pathway analysis informs a synergistic combination therapy targeting PTEN/PI3K and EGFR pathways for basal-like breast cancer.
She QB; Gruvberger-Saal SK; Maurer M; Chen Y; Jumppanen M; Su T; Dendy M; Lau YK; Memeo L; Horlings HM; van de Vijver MJ; Isola J; Hibshoosh H; Rosen N; Parsons R; Saal LH
BMC Cancer; 2016 Aug; 16():587. PubMed ID: 27484095
[TBL] [Abstract][Full Text] [Related]
13. NRF1 motif sequence-enriched genes involved in ER/PR -ve HER2 +ve breast cancer signaling pathways.
Ramos J; Das J; Felty Q; Yoo C; Poppiti R; Murrell D; Foster PJ; Roy D
Breast Cancer Res Treat; 2018 Nov; 172(2):469-485. PubMed ID: 30128822
[TBL] [Abstract][Full Text] [Related]
14. Rho GTPase Transcriptome Analysis Reveals Oncogenic Roles for Rho GTPase-Activating Proteins in Basal-like Breast Cancers.
Lawson CD; Fan C; Mitin N; Baker NM; George SD; Graham DM; Perou CM; Burridge K; Der CJ; Rossman KL
Cancer Res; 2016 Jul; 76(13):3826-37. PubMed ID: 27216196
[TBL] [Abstract][Full Text] [Related]
15. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
[TBL] [Abstract][Full Text] [Related]
16. The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.
Mansour M; Haupt S; Chan AL; Godde N; Rizzitelli A; Loi S; Caramia F; Deb S; Takano EA; Bishton M; Johnstone C; Monahan B; Levav-Cohen Y; Jiang YH; Yap AS; Fox S; Bernard O; Anderson R; Haupt Y
Cancer Res; 2016 Jul; 76(14):4236-48. PubMed ID: 27231202
[TBL] [Abstract][Full Text] [Related]
17. Raf-1 oncogenic signaling is linked to activation of mesenchymal to epithelial transition pathway in metastatic breast cancer cells.
Leontovich AA; Zhang S; Quatraro C; Iankov I; Veroux PF; Gambino MW; Degnim A; McCubrey J; Ingle J; Galanis E; D'Assoro AB
Int J Oncol; 2012 Jun; 40(6):1858-64. PubMed ID: 22447278
[TBL] [Abstract][Full Text] [Related]
18. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte-derived IL-6 and leptin promote breast Cancer metastasis via upregulation of Lysyl Hydroxylase-2 expression.
He JY; Wei XH; Li SJ; Liu Y; Hu HL; Li ZZ; Kuang XH; Wang L; Shi X; Yuan ST; Sun L
Cell Commun Signal; 2018 Dec; 16(1):100. PubMed ID: 30563531
[TBL] [Abstract][Full Text] [Related]
20. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer.
Kuukasjärvi T; Karhu R; Tanner M; Kähkönen M; Schäffer A; Nupponen N; Pennanen S; Kallioniemi A; Kallioniemi OP; Isola J
Cancer Res; 1997 Apr; 57(8):1597-604. PubMed ID: 9108466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
